Doctor Shingo Matsumoto
Toho University, Tokyo (Japan)
Member of:
/f/125658/3386x1417/951de003e4/hfa-acronym-name-rgb.png)
Should a decline in eGFR to <30 mL/min always lead to discontinuation of an MRA?
Event: Heart Failure 2024
Topic: Pharmacotherapy
Session: Treating heart failure with diabetes and renal disease
Asymptomatic versus symptomatic hypotension in HFrEF: Findings with sacubitril/valsartan in PARADIGM-HF
Event: Heart Failure 2024
Topic: Pharmacotherapy
Session: Chronic heart failure - treatment 7
Effect of eplerenone according to duration of heart failure in EMPHASIS-HF: It is never too late to start an MRA in HFrEF
Event: ESC Congress 2023
Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)
Session: Insights from recent HFrEF trials 2
Calcium channel blocker and outcomes in patients with heart failure and mildly reduced or preserved ejection fraction
Event: Heart Failure 2023
Topic: Pharmacotherapy
Session: Chronic heart failure - treatment 3
Lack of brain natriuretic peptide reduction at 30-day significantly predicts worse clinical outcomes in non-responders of cardiac resynchronization therapy
Event: Heart Failure 2018
Topic: Cardiac Resynchronisation Therapy (CRT)
Session: Chronic Heart Failure – Treatment
Heart rate during hypothermia therapy is an independent predictor of clinical outcomes in patients resuscitated from out-of-hospital cardiac arrest due to acute coronary syndrome
Event: ESC Congress 2017
Topic: CPR (cardiopulmonary resuscitation)
Session: Acute cardiac care
Heart rate after resuscitation predicts clinical outcomes in patients with out-of-hospital cardiac arrest due to acute coronary syndrome.
Event: ESC Congress 2017
Topic: CPR (cardiopulmonary resuscitation)
Session: Acute cardiac care
